Wealth Quarterback LLC Bluebird Bio, Inc. Transaction History

Wealth Quarterback LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$2.94 - $5.23 $873 - $1,553	-297 Closed	0 $0
Q2 2021 Aug 11, 2021	BUY	$18.04 - $22.09 $5,357 - $6,560	297 New	297 $10,000
Q2 2020 Aug 17, 2020	SELL	$27.12 - $45.97 $8,054 - $13,653	-297 Closed	0 $0
Q1 2020 May 14, 2020	SELL	$26.16 - $63.5 $762,956 - $1.85 Million	-29,165 Reduced 98.99%	297 $8,000
Q4 2019 Feb 27, 2020	BUY	$46.96 - $61.67 $1.38 Million - $1.82 Million	29,462 New	29,462 $1.67 Million

27M

191K

299K

Ticker BLUE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 77,121,800
Market Cap $561M
Description
bluebird bio, Inc., a biotechnology company, researches, develops, and commercializes transformative gene therapies for severe genetic diseases. Its product candidates for severe genetic diseases include betibeglogene autotemcel for the treatment of transfusion-dependent ß-thalassemia; lovotibeglogene autotemcel for the treatment of sickle cell ...

Get notified when there are updates to the investment portfolio of Wealth Quarterback LLC, based on Form 13F filings with the SEC.

Stay updated on Wealth Quarterback LLC with notifications on news.